Edgewise Therapeutics (EWTX) PT Raised to $25 at JPMorgan
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Price: $41.98 --0%
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 9 | New: 19
Rating Summary:
11 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 9 | New: 19
Join SI Premium – FREE
JPMorgan analyst Tessa Romero raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $25.00 (from $24.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Morgan Stanley Assumes Adyen NV (ADYEN:NA) (ADYYF) at Overweight
- Morgan Stanley Upgrades Ariston Holding NV (ARIS:IM) to Equalweight
- Somnigroup (SGI) PT Raised to $102 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
